0 0 0
This online shop is using cookies to give you the best shopping experience. Thereby for example the session information or language setting are stored on your computer. Without cookies the range of the online shop's functionality is limited. If you don't agree, please click here.

Nasir, Coppola Neuroendocrine Tumors: Pathology, Molecular and Therapeutic Advances

A Case Based Review

ISBN: 978-1-4939-3424-9

Edition: 1st Ed.

Publication date: September 2016

Cover: Hardcover

Pages: 542 p.

Illustrations: 270 ill.

Publisher: Springer

Delivery times, dependent on availability and publisher: between 2 and 14 days from when you complete the order.

Description

  • Written by an outstanding team of practicing neuroendocrine pathologists and oncologists
  • Case-based review format provides practical diagnostic and therapeutic approach
  • Focuses on the newer histological grading schemes of the major neuroendocrine societies

This text brings together the diagnostic and clinical expertise of an outstanding team of practicing neuroendocrine pathologists and oncologists. The case-based review format provides a practical diagnostic and therapeutic approach to illustrate real-life examples of a diverse range of neuroendocrine tumors that were diagnosed and worked-up in the multi-disciplinary setting of one of the leading academic cancer centers in the United States. In addition to the clinic-pathologic and molecular advances in the field of neuroendocrine oncology, this book focuses on the newer histological grading schemes by the North American NeuroEndocrine Tumor Society (NANETS), European NeuroEndocrine Tumor Society (ENETS) and the World Health Organization (WHO) and the recently proposed pathologic staging systems by the AJCC, WHO and ENETS. Individual case discussions are integrated with pertinent progress in molecular characterization of these unusual neoplasms. The balanced case content allows the reader to develop a comprehensive and practical understanding of the current trends in the pathology and molecular diagnosis of neuroendocrine neoplasms.